Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Vetjournal /     
 
Is radiotherapy in cutaneous grade II mast cell tumors mandatory?
A very important question, because cutaneous mast cell tumors are very common and radiotherapy is not always and everywhere available. The answer: If these tumors are completely excised, adjuvant radiotherapy might not be necessary in the majority of dogs, as this study shows.

A retrospective study was performed on 31 dogs with completely excised, grade II, cutaneous mast cell tumors in order to determine recurrence rates and sites.

Distant tumor recurrence developed in 22% of dogs, and local tumor recurrence developed in 11% of dogs; however, the vast majority of these animals were incompletely staged initially.

Complete surgical excision of grade II mast cell tumors was associated with effective local control in 89% of these dogs.

Therefore, adjuvant radiation therapy might not be indicated in the majority of dogs with complete surgical excision.

Source: Chick Weisse, Frances S. Shofer, Karin Sorenmo (2002): Recurrence Rates and Sites for Grade II Canine Cutaneous Mast Cell Tumors Following Complete Surgical Excision. In: Journal of the American Animal Hospital Association 38:71-73 (2002)



Tell a friend   |   Print version   |   Send this article

VETJOURNAL

WSAVA 2019


  • 25th FECAVA EuroCongress 4-9 September 2019, St. Petersburg / Russia
  • ESVN-ECVN Symposium 2018
  • ESAVS
  • VetAgenda
  • Lab in Practice - Clinical Pathology
  • European Master of Small Animal Veterinary Medicine
  • SEVC 2014
  • ESAVS - Neuropathology & MRI
  • CongressMed 2014
  • ACVIM 2014
  • VetContact


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved